PT Medela Potentia Tbk Named Among ‘Fortune Indonesia 100: 2026’, Reflecting 2025 Revenue Performance
PT Medela Potentia Tbk (MDLA) has been named among the ‘Fortune Indonesia 100: 2026’, a ranking of Indonesia’s 100 biggest companies based on fiscal year 2025 revenue. MDLA ranked 82nd, with revenue of Rp14.89 trillion recorded in 2025.
MDLA’s inclusion in the ranking marks a significant milestone in the Company’s journey, coming approximately one year after its shares were listed on the Indonesia Stock Exchange on April 15, 2025. As a publicly listed company, MDLA is committed to transparent disclosure of its financial and operational performance, including its fiscal year 2025 revenue, which served as the basis for the Fortune Indonesia 100 ranking.
The recognition was presented during the Fortune Indonesia 100 Gala, held at Hotel Mulia Senayan, Jakarta, on Thursday, September 17, 2026. Mr. Hendra Soeprajitno, Editor-in-Chief of Fortune Indonesia, presented the commemorative plaque to Mrs. Juliwaty, President Director of PT Medela Potentia Tbk. The occasion was also attended by Mr. Edbert Orotodan, Director of PT Medela Potentia Tbk.
The gala was attended by Mr. Winston Utomo, Founder & Chief Executive Officer of IDN Media, and Mr. William Utomo, Co-Founder & Chief Operating Officer of IDN Media. Mr. William shared that companies featured in the Fortune Indonesia 100: 2026 recorded minimum revenue of Rp12.31 trillion, representing an approximately 10% increase from the threshold applied in the previous edition. He also noted that nine of the 100 companies on the list are led by women.
“Companies included in the Fortune Indonesia 100 must record revenue of at least Rp12.31 trillion,” said William.
“Thank you to Fortune Indonesia and IDN for recognizing Medela Potentia as one of Indonesia’s 100 biggest companies. We are very grateful for this achievement, which reflects the contributions of our business partners, customers, and employees,” said Mrs. Juliwaty.
One of Four Healthcare Companies Featured
MDLA’s inclusion in the Fortune Indonesia 100: 2026 also places the Company among the four healthcare companies featured in this year’s ranking.
The recognition reflects the Company’s continued efforts to build an integrated healthcare business ecosystem through a diversified portfolio spanning pharmaceutical and healthcare product distribution, medical devices, medical device manufacturing, and digital healthcare solutions.
With more than 45 years of experience in the healthcare industry, MDLA continues to strengthen its capabilities and infrastructure to help expand access to healthcare products and solutions across Indonesia.
These efforts include expanding and strengthening its distribution network, developing its business portfolio, accelerating digital transformation, and advancing sustainability initiatives as part of the Company’s long-term growth strategy.
